FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gil Melmed

Research Profile

Disorders

Living Beings

Young Adult

Anatomy

Colonic Pouches

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Bijal Surti; Stephan R Targan; Eric A Vasiliauskas; Andrew Ippoliti; Dermot P B McGovern; David Q Shih; Peter Simpson; Brennan Spiegel; Gil Y Melmed
Assessing health status in inflammatory bowel disease using a novel single-item numeric rating scale.
Lloyd Mayer; Gil Y Melmed; William M Pandak; Denise Payne; Herbert Faleck; Stephen B Hanauer; Robert J Hariri; Kristine Johnson; Steven A Fischkoff
Safety and tolerability of human placenta-derived cells (PDA001) in treatment-resistant crohn's disease: a phase 1 study.
Gil Y Melmed; Amy Moynihan; David T Rubin; R Balfour Sartor; Ronald M Schwartz; Corey A Siegel; Brennan M Spiegel; John I Allen; Robert Cima; Jean-Frederic Colombel; Themistocles Dassopoulos; Lee A Denson; Sharon Dudley-Brown; Andrew Garb; Stephen B Hanauer; Michael D Kappelman; James D Lewis; Isabelle Lynch; Douglas C Wolf; Thomas A Ullman
Quality indicators for inflammatory bowel disease: development of process and outcome measures.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gil Melmed (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Bijal Surti; Stephan R Targan; Eric A Vasiliauskas; Andrew Ippoliti; Dermot P B McGovern; David Q Shih; Peter Simpson; Brennan Spiegel; Gil Y Melmed
Assessing health status in inflammatory bowel disease using a novel single-item numeric rating scale.
Digestive diseases and sciences 2013;58(5):1313-21.
2013: Lloyd Mayer; Gil Y Melmed; William M Pandak; Denise Payne; Herbert Faleck; Stephen B Hanauer; Robert J Hariri; Kristine Johnson; Steven A Fischkoff
Safety and tolerability of human placenta-derived cells (PDA001) in treatment-resistant crohn's disease: a phase 1 study.
Inflammatory bowel diseases 2013;19(4):754-60.
2013: Gil Y Melmed; Amy Moynihan; David T Rubin; R Balfour Sartor; Ronald M Schwartz; Corey A Siegel; Brennan M Spiegel; John I Allen; Robert Cima; Jean-Frederic Colombel; Themistocles Dassopoulos; Lee A Denson; Sharon Dudley-Brown; Andrew Garb; Stephen B Hanauer; Michael D Kappelman; James D Lewis; Isabelle Lynch; Douglas C Wolf; Thomas A Ullman
Quality indicators for inflammatory bowel disease: development of process and outcome measures.
Inflammatory bowel diseases 2013;19(3):662-8.
2013: Quy Le; Dermot P B McGovern; Gil Y Melmed; Zuri Murrell; David Shih; Stephan Targan; Eric A Vasiliauskas; Marla C Dubinsky; Andrew Ippoliti; Manreet Kaur; Phillip R Fleshner
Surgical outcome of ileal pouch-anal anastomosis when used intentionally for well-defined Crohn's disease.
Inflammatory bowel diseases 2013;19(1):30-6.
2012: Adam S Cheifetz; Shane M Devlin; P M Irving; J Jones; Gilaad G Kaplan; Peter Kozuch; Gil Y Melmed; L Raffals; M Sparrow; B Spiegel; J Talley; Fernando S Velayos; L Baidoo; B Bressler; Corey A Siegel
Setting priorities for comparative effectiveness research in inflammatory bowel disease: results of an international provider survey, expert RAND panel, and patient focus groups.
Inflammatory bowel diseases 2012;18(12):2294-300.
2012: Karen N Zaghiyan; Gil Y Melmed; Zuri Murrell; Phillip R Fleshner
High-dose perioperative corticosteroids in steroid-treated patients undergoing major colorectal surgery: necessary or overkill?
American journal of surgery 2012;204(4):481-6.
2012: Robert J Basseri; Dror Berel; Phillip R Fleshner; Bing Hu; Andrew Ippoliti; Juan Lechago; Gil Y Melmed; Stephan R Targan; Eric A Vasiliauskas; Maria E Vassilaki; Benjamin Basseri; Konstantinos A Papadakis
Colorectal cancer screening and surveillance in Crohn's colitis.
Journal of Crohn's & colitis 2012;6(8):824-9.
2012: Seper Dezfoli; Gil Y Melmed
Vaccination issues in patients with inflammatory bowel disease receiving immunosuppression.
Gastroenterology & hepatology 2012;8(8):504-12.
2012: Karen Zaghiyan; Gil Y Melmed; Zuri Murrell; Phillip R Fleshner
Safety and feasibility of using low-dose perioperative intravenous steroids in inflammatory bowel disease patients undergoing major colorectal surgery: A pilot study.
Surgery 2012;152(2):158-63.
2012: Evan C White; Marla C Dubinsky; Andrew Ippoliti; Dermot P B McGovern; Gil Y Melmed; Stephan Targan; Eric A Vasiliauskas; Phillip R Fleshner
Does preoperative immunosuppression influence unplanned hospital readmission after surgery in patients with Crohn's disease?
Diseases of the colon and rectum 2012;55(5):563-8.
2012: Brian Huang; Gil Y Melmed; David Q Shih
Facial ulceration in a patient with Crohn's disease.
Gastroenterology 2012;142(5):1071, 1258.
2012: Nikhil Agarwal; Robert W Frenck; Marc Kaneshiro; Kevin Ollington; Gil Y Melmed
Are immunosuppressive medications associated with decreased responses to routine immunizations? A systematic review.
Vaccine 2012;30(8):1413-24.
2012: Kevin F Ollington; Janet Morgan; Daniel Brelian; Phillip R Fleshner; Quy Le; Gil Y Melmed
Comparison of adenoma detection rates between gastroenterologists and colorectal surgeons.
The American surgeon 2012;78(2):269-70.
2011: Karen Zaghiyan; Gil Y Melmed; Zuri Murrell; Phillip R Fleshner
Are high-dose perioperative steroids necessary in patients undergoing colorectal surgery treated with steroid therapy within the past 12 months?
The American surgeon 2011;77(10):1295-9.
2011: Talin Haritunians; Andrew Ippoliti; Michelle Jones; Lily King; Esther Leshinsky-Silver; Arie Levine; Dermot P B McGovern; Gil Y Melmed; Emebet Mengesha; Jerome I Rotter; David Q Shih; Stephan R Targan; Robert J Barrett; Carrie Derkowski; Marla C Dubinsky; Debra Dutridge; Phillip R Fleshner; Eric A Vasilauskas; Shabnam Ziaee; Kent D Taylor
Variants in ZNF365 isoform D are associated with Crohn's disease.
Gut 2011;60(8):1060-7.
2011: Yosef Nasseri; Som Kohanzadeh; Zuri Murrell; Dror Berel; Gil Y Melmed; Phillip R Fleshner
Phantom publications among applicants to a colorectal surgery residency program.
Diseases of the colon and rectum 2011;54(2):220-5.
2010: Talin Haritunians; Kent D Taylor; Stephan R Targan; Marla C Dubinsky; Andrew Ippoliti; Soonil Kwon; Xiuqing Guo; Gil Y Melmed; Dror Berel; Emebet Mengesha; Bruce M Psaty; Nicole L Glazer; Eric A Vasiliauskas; Jerome I Rotter; Phillip R Fleshner; Dermot P B McGovern
Genetic predictors of medically refractory ulcerative colitis.
Inflammatory bowel diseases 2010;16(11):1830-40.
2010: Dermot P B McGovern; Michelle Jones; Kent D Taylor; Kristin Marciante; Xiaofei Yan; Marla C Dubinsky; Andy Ippoliti; Eric A Vasiliauskas; Dror Berel; Carrie Derkowski; Deb Dutridge; Phil Fleshner; David Q Shih; Gil Y Melmed; Emebet Mengesha; Lily King; Sheila Pressman; Talin Haritunians; Xiuqing Guo; Stephan R Targan; Jerome I Rotter
Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease.
Human molecular genetics 2010;19(17):3468-76.
2010: Gil Y Melmed; Brennan M R Spiegel; Brian Bressler; Adam S Cheifetz; Shane M Devlin; Laura E Harrell; Peter M Irving; Jennifer Jones; Gilaad G Kaplan; Patricia L Kozuch; Fernando S Velayos; Leonard Baidoo; Miles P Sparrow; Corey A Siegel
The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's disease: one size does not fit all.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2010;8(8):655-9.
2010: Andrew Ippoliti; Shane Devlin; Ling Mei; Huiying Yang; Konstantinos A Papadakis; Eric A Vasiliauskas; Dermot P B McGovern; Maria Abreu; Gil Y Melmed; Omid Shaye; Pedram Enayati; Gary Chen; Jennifer Choi; Kent Taylor; Carol J Landers; Jerome I Rotter; Stephan R Targan
Combination of innate and adaptive immune alterations increased the likelihood of fibrostenosis in Crohn's disease.
Inflammatory bowel diseases 2010;16(8):1279-85.
2010: Evan White; Gil Y Melmed; Eric A Vasiliauskas; Marla C Dubinsky; Dror Berel; Stephan R Targan; Phillip R Fleshner
A prospective analysis of clinical variables, serologic factors, and outcome of ileal pouch-anal anastomosis in patients with backwash ileitis.
Diseases of the colon and rectum 2010;53(7):987-94.
2010: Zuri Murrell; Eric A Vasiliauskas; Gil Y Melmed; Simon Lo; Stephan Targan; Phillip R Fleshner
Preoperative wireless capsule endoscopy does not predict outcome after ileal pouch-anal anastomosis.
Diseases of the colon and rectum 2010;53(3):293-300.
2010: Gil Y Melmed; Stephan R Targan
Future biologic targets for IBD: potentials and pitfalls.
Nature reviews. Gastroenterology & hepatology 2010;7(2):110-7.
2010: Laura Hwang; Kimberly Low; Reza Khoshini; Gil Y Melmed; Ara Sahakian; Marc Makhani; Venkata Pokkunuri; Mark Pimentel
Evaluating breath methane as a diagnostic test for constipation-predominant IBS.
Digestive diseases and sciences 2010;55(2):398-403.
2010: Yosef Nasseri; Gil Y Melmed; Hanlin L Wang; Stephan Targan; Phillip R Fleshner
Rigorous histopathological assessment of the colectomy specimen in patients with inflammatory bowel disease unclassified does not predict outcome after ileal pouch-anal anastomosis.
The American journal of gastroenterology 2010;105(1):155-61.
2010: Gil Y Melmed; Nik Agarwal; Robert W Frenck; Andrew Ippoliti; Patricio Ibanez; Konstantinos A Papadakis; Peter Simpson; Cristina Barolet-Garcia; Joel Ward; Stephan R Targan; Eric A Vasiliauskas
Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease.
The American journal of gastroenterology 2010;105(1):148-54.
2010: Corey A Siegel; Gil Y Melmed; Thomas A Ullman
Improving quality of care in IBD: a STEEEP challenge.
Inflammatory bowel diseases 2010;16(1):134-6.
2010: Mark Pimentel; Laura Hwang; Gil Y Melmed; Kimberly Low; Eric Vasiliauskas; Andrew Ippoliti; Janet Yang; Sheila Lezcano; Jeffrey L Conklin; Ara Sahakian
New clinical method for distinguishing D-IBS from other gastrointestinal conditions causing diarrhea: the LA/IBS diagnostic strategy.
Digestive diseases and sciences 2010;55(1):145-9.
2009: Gil Y Melmed; Saibel Kar; Ivor Geft; Simon K Lo
A new method for endoscopic closure of gastrocolonic fistula: novel application of a cardiac septal defect closure device (with video).
Gastrointestinal endoscopy 2009;70(3):542-5.
2009: Gil Y Melmed
Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics.
Inflammatory bowel diseases 2009;15(9):1410-6.
2009: Corey A Siegel; Gil Y Melmed
Predicting response to Anti-TNF Agents for the treatment of crohn's disease.
Therapeutic advances in gastroenterology 2009;2(4):245-51.
2009: Zuri A Murrell; Gil Y Melmed; Andrew Ippoliti; Eric A Vasiliauskas; Marla C Dubinsky; Stephan R Targan; Phillip R Fleshner
A prospective evaluation of the long-term outcome of ileal pouch-anal anastomosis in patients with inflammatory bowel disease-unclassified and indeterminate colitis.
Diseases of the colon and rectum 2009;52(5):872-8.
2009: Gil Y Melmed
Clarithromycin for Crohn's: A flash in the pan?
Inflammatory bowel diseases 2009;15(4):639-40.
2009: Brennan M R Spiegel; Wayne Ho; Eric Esrailian; Stephan R Targan; Peter Higgins; Corey A Siegel; Marla Dubinsky; Gil Y Melmed
Controversies in ulcerative colitis: a survey comparing decision making of experts versus community gastroenterologists.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2009;7(2):168-74, 174.e1.
2008: Gil Y Melmed
Vaccinations and the Utilization of Immunosuppressive IBD Therapy.
Gastroenterology & hepatology 2008;4(12):859-61.
2008: Miles P Sparrow; Fernando S Velayos; Leonard Baidoo; Brian Bressler; Adam S Cheifetz; Shane M Devlin; Laura E Harrell; Peter M Irving; Jennifer Jones; Patricia L Kozuch; Gil Y Melmed; Corey A Siegel
Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group.
Gastroenterology & hepatology 2008;4(10):713-20.
2008: Gil Y Melmed; Stephan R Targan; Uma Yasothan; Delphine Hanicq; Peter Kirkpatrick
Certolizumab pegol.
Nature reviews. Drug discovery 2008;7(8):641-2.
2008: Gil Y Melmed; Phillip R Fleshner; Konstantinos A Papadakis
Proximal small intestinal CD detected by CE.
Gastrointestinal endoscopy 2008;68(1):202-3; author reply 203-4.
2008: Peter W Simpson; Gil Y Melmed; Marla Dubinksy
The impact of medical therapy for inflammatory bowel disease on pregnancy outcome.
The American journal of gastroenterology 2008;103(3):805-6.
2008: Gil Y Melmed; Shane M Devlin; George Vlotides; Deepti Dhall; Soraya Ross; Run Yu; Shlomo Melmed
Anti-aging therapy with human growth hormone associated with metastatic colon cancer in a patient with Crohn's colitis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2008;6(3):360-3.
2008: Gil Y Melmed; Phillip R Fleshner; Ovunc Bardakcioglu; Andrew Ippoliti; Eric A Vasiliauskas; Konstantinos A Papadakis; Marla C Dubinsky; Carol J Landers; Jerome I Rotter; Stephan R Targan
Family history and serology predict Crohn's disease after ileal pouch-anal anastomosis for ulcerative colitis.
Diseases of the colon and rectum 2008;51(1):100-8.
2007: Gil Y Melmed; Robert Elashoff; Gary C Chen; Igor Nastaskin; Konstantinos A Papadakis; Eric A Vasiliauskas; Weiqing Liu; Carol J Landers; Andrew Ippoliti; Stephan R Targan
Predicting a change in diagnosis from ulcerative colitis to Crohn's disease: a nested, case-control study.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2007;5(5):602-8; quiz 525.
2007: Shane M Devlin; Huiying Yang; Andrew Ippoliti; Kent D Taylor; Carol J Landers; Xiaowen Su; Maria Abreu; Konstantinos A Papadakis; Eric A Vasiliauskas; Gil Y Melmed; Phillip R Fleshner; Ling Mei; Jerome I Rotter; Stephan R Targan
NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives.
Gastroenterology 2007;132(2):576-86.
2006: Gil Y Melmed; Andrew Ippoliti; Konstantinos A Papadakis; Tram T Tran; Jaime L Birt; Susie K Lee; Robert W Frenck; Stephan R Targan; Eric A Vasiliauskas
Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses.
The American journal of gastroenterology 2006;101(8):1834-40.
2005: Gil Y Melmed; Simon K Lo
Capsule endoscopy: practical applications.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2005;3(5):411-22.
2004: Gil Y Melmed; Maria Abreu
New insights into the pathogenesis of inflammatory bowel disease.
Current gastroenterology reports 2004;6(6):474-81.
2004: Robert W Dubois; Gil Y Melmed; James M Henning; Myriam Bernal
Risk of Upper Gastrointestinal Injury and Events in Patients Treated With Cyclooxygenase (COX)-1/COX-2 Nonsteroidal Antiinflammatory Drugs (NSAIDs), COX-2 Selective NSAIDs, and Gastroprotective Cotherapy: An Appraisal of the Literature.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2004;10(4):178-89.
2003: Gil Y Melmed; Lisa S Thomas; Nahee Lee; Samuel Y Tesfay; Katie Lukasek; Kathrin S Michelsen; Yuehua Zhou; Bing Hu; Moshe Arditi; Maria Abreu
Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(3):1406-15.
2002: Gil Y Melmed; Lorna Kwan; Kristen Reid; Mark S Litwin
Quality of life at the end of life: trends in patients with metastatic prostate cancer.
Urology 2002;59(1):103-9.
2001: Mark S Litwin; Gil Y Melmed; T Nakazon
Life after radical prostatectomy: a longitudinal study.
The Journal of urology 2001;166(2):587-92.